1. Repositorio Salud Andalucía

Browsing by Author Pasquau, Juan

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 23  next >
PreviewTitleAuthor(s)Issue Date
ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR study.Podzamczer, Daniel; Rozas, Nerea; Domingo, Pere; Ocampo, Antonio; Van den Eynde, Eva; Deig, Elisabeth; Vergara, Antonio; Knobel, Hernando; Pasquau, Juan; Antela, Antonio; Crespo, Manuel; Clotet, Bonaventure; Muñoz, Jessica; Fernandez, Pedro; Geijo, Paloma; Rodríguez de Castro, Eduardo; Diz, Julio; Casado, Araceli; Torres, Covadonga2-Nov-2014
Assisted reproductive technology and obstetric outcome in couples when the male partner has a chronic viral disease.Molina, Irene; Gonzalvo, María del Carmen; Clavero, Ana; López-Ruz, Miguel Angel; Mozas, Juan; Pasquau, Juan; Sampedro, Antonio; Martínez, Luis; Castilla, José AntonioJan-2014
CNS safety at 48-week of switching to ATV/r plus 3TC or two nucleos(t)ides in HIV-suppressed patients on stable ART: the SALT neurocognitive sub-study.Pérez Valero, Ignacio; Pasquau, Juan; Rubio, Rafael; Ribero, Antonio; Santos, Jose; Sanz, Jesus; Mariño, Ana; Crespo, Manel; Hernandez, Jose; Iribarren, Jose Antonio; Gutierrez, Felix; Terron, Alberto; Esteban, Herminia; Pérez-Molina, Jose Antonio2-Nov-2014
DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci.Hidalgo-Tenorio, Carmen; Vinuesa, David; Plata, Antonio; Martin Dávila, Pilar; Iftimie, Simona; Sequera, Sergio; Loeches, Belén; Lopez-Cortés, Luis Eduardo; Fariñas, Mari Carmen; Fernández-Roldan, Concepción; Javier-Martinez, Rosario; Muñoz, Patricia; Arenas-Miras, Maria Del Mar; Martínez-Marcos, Francisco Javier; Miró, Jose Maria; Herrero, Carmen; Bereciartua, Elena; De Jesus, Samantha E; Pasquau, Juan19-Oct-2019
DOLAMA study: Effectiveness, safety and pharmacoeconomic analysis of dual therapy with dolutegravir and lamivudine in virologically suppressed HIV-1 patients.Hidalgo-Tenorio, Carmen; Cortés, Luis López; Gutiérrez, Alicia; Santos, Jesús; Omar, Mohamed; Gálvez, Carmen; Sequera, Sergio; Jesús, Samantha Eisabeth De; Téllez, Franciso; Fernández, Elisa; García, Coral; Pasquau, Juan2019
DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks).Hidalgo-Tenorio, Carmen; Pasquau, Juan; Vinuesa, David; Ferra, Sergio; Terrón, Alberto; SanJoaquín, Isabel; Payeras, Antoni; Martínez, Onofre Juan; López-Ruz, Miguel Ángel; Omar, Mohamed; de la Torre-Lima, Javier; López-Lirola, Ana; Palomares, Jesús; Blanco, José Ramón; Montero, Marta; García-Vallecillos, Coral4-Mar-2022
Effect of monotherapy with darunavir/cobicistat on viral load and semen quality of HIV-1 patients.López-Ruz, Miguel A; López-Zúñiga, Miguel A; Gonzalvo, María Carmen; Sampedro, Antonio; Pasquau, Juan; Hidalgo, Carmen; Rosario, Javier; Castilla, Jose Antonio24-Apr-2018
Effect of Monotherapy with Darunavir/Ritonavir on Viral Load in Seminal Fluid, and Quality Parameters of Semen in HIV-1-Positive Patients.Lopez-Ruz, Miguel A; Navas, Purificación; López-Zúñiga, Miguel A; Gonzalvo, María Carmen; Sampedro, Antonio; Pasquau, Juan; Hidalgo-Tenorio, Carmen; Javier, Rosario; Castilla, José A21-Jul-2016
Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study).Pasquau, Juan; de Jesus, Samantha E; Arazo, Piedad; Crusells, María J; Ríos, María J; Lozano, Fernando; de la Torre, Javier; Galindo, María J; Carmena, Jorge; Santos, Jesús; Tornero, Carlos; Verdejo, Guillermo; Samperiz, Gloria; Palacios, Zaira; Hidalgo-Tenorio, Carmen; RIDAR Study Group28-Feb-2019
Effectiveness of the Quadrivalent HPV Vaccine in Preventing Anal ≥ HSILs in a Spanish Population of HIV+ MSM Aged > 26 Years.Hidalgo-Tenorio, Carmen; Pasquau, Juan; Omar-Mohamed, Mohamed; Sampedro, Antonio; López-Ruz, Miguel A; López Hidalgo, Javier; Ramírez-Taboada, Jessica20-Jan-2021
Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study.López-Cortés, Luis F; Viciana, Pompeyo; Ruiz-Valderas, Rosa; Pasquau, Juan; Ruiz, Josefa; Lozano, Fernando; Merino, Dolores; Vergara, Antonio; Terrón, Alberto; González, Luis; Rivero, Antonio; Muñoz-Sanz, Agustin17-Mar-2010
Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study.Garcia, Federico; Poveda, Eva; Pérez-Elías, Maria Jesús; Hernández Quero, José; Ribas, Maria Angels; Martínez-Madrid, Onofre J; Flores, Juan; Crespo, Manel; Gutiérrez, Félix; García-Deltoro, Miguel; Imaz, Arkaitz; Ocampo, Antonio; Artero, Arturo; Blanco, Francisco; Bernal, Enrique; Pasquau, Juan; Mínguez-Gallego, Carlos; Pérez, Núria; Aiestarán, Aintzane; Paredes, Roger2-Nov-2014
High prevalence and diversity of HIV-1 non-B genetic forms due to immigration in southern Spain: A phylogeographic approach.Pérez-Parra, Santiago; Chueca, Natalia; Álvarez, Marta; Pasquau, Juan; Omar, Mohamed; Collado, Antonio; Vinuesa, David; Lozano, Ana Belen; Yebra, Gonzalo; García, Federico30-Oct-2017
High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial.Pasquau, Juan; Hidalgo-Tenorio, Carmen; Montes, María Luisa; Romero-Palacios, Alberto; Vergas, Jorge; Sanjoaquín, Isabel; Hernández-Quero, José; Aguirrebengoa, Koldo; Orihuela, Francisco; Imaz, Arkaitz; Ríos-Villegas, María José; Flores, Juan; Fariñas, María Carmen; Vázquez, Pilar; Galindo, María José; García-Mercé, Isabel; Lozano, Fernando; de Los Santos, Ignacio; de Jesus, Samantha Elizabeth; García-Vallecillos, Coral; QoLKAMON STUDY GROUP12-Apr-2018
Monotherapy with darunavir/ritonavir is effective and safe in clinical practice.Pasquau, Juan; López-Cortés, Luis; Mayorga, Maria Isabel; Viciana, Pompeyo; Arenas, María Del Mar; Ríos, Maria José; Hernández-Quero, José; Castaño, Manuel; Merino, María Dolores; Márquez, Manuel; Vergara, Antonio; Terrón, Alberto; Téllez, Francisco; Hidalgo-Tenorio, Carmen2-Nov-2014
Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial.Pérez-Valero, Ignacio; Pasquau, Juan; Rubio, Rafael; Rivero, Antonio; Santos, José; Sanz, Jesus; Mariño, Ana; Crespo, Manel; Hernández-Quero, Jose; Iribarren, José Antonio; Gutiérrez, Félix; Terrón, Alberto; Esteban, Herminia; Pérez-Molina, José Antonio; GESIDA 7011 Study Group members2018
No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients.Gutierrez-Valencia, Alicia; García, Coral; Viciana, Pompeyo; Milanés-Guisado, Yusnelkis; Fernandez-Magdaleno, Tamara; Espinosa, Nuria; Pasquau, Juan; López-Cortés, Luis Fernando20-Sep-2018
Phylodynamic and Phylogeographic Profiles of Subtype B HIV-1 Epidemics in South SpainPerez-Parra, Santiago; Chueca, Natalia; Alvarez, Marta; Pasquau, Juan; Omar, Mohamed; Collado, Antonio; Vinuesa, David; Lozano, Ana B.; Yebra, Gonzalo; Garcia, Federico21-Dec-2016
Phylodynamic and Phylogeographic Profiles of Subtype B HIV-1 Epidemics in South Spain.Pérez-Parra, Santiago; Chueca, Natalia; Álvarez, Marta; Pasquau, Juan; Omar, Mohamed; Collado, Antonio; Vinuesa, David; Lozano, Ana B; Yebra, Gonzalo; García, Federico21-Dec-2016
Phylodynamic and Phylogeographic Profiles of Subtype B HIV-1 Epidemics in South Spain.Pérez-Parra, Santiago; Chueca, Natalia; Álvarez, Marta; Pasquau, Juan; Omar, Mohamed; Collado, Antonio; Vinuesa, David; Lozano, Ana B; Yebra, Gonzalo; García, Federico21-Dec-2016
Showing results 1 to 20 of 23  next >